Bringing the fundamentals into focus…
Back to Takeda Pharmaceutical Company Limited
How Takeda Pharmaceutical Company Limited stacks up
TAK · against 552 other Healthcare companies listed in US-listed
Overall
30/ 100
Near the bottom of its peers.
Ranked #430 of 553 · scores higher than 19% of peers
Bars: peers in each 10-point band of the overall score142 peers with an overall score of 30–39, including TAK · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TAK| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 430 | 1.7B USD | 30 | 8 | 25 | 2 | 0 / 2 | |
| 430 | 1.7B USD | 30 | 8 | 29 | 4 | 0 / 2 | |
| 430 | 549M USD | 30 | 8 | 13 | 5 | 0 / 2 | |
| 430 | 200M USD | 30 | 46 | 26 | 2 / 2 | ||
| 430 | 66.3B USD | 30 | 44 | 20 | 37 | 2 / 2 | |
| 449 | 377M USD | 29 | 8 | 96 | 10 | 2 / 2 | |
| 449 | 4.6B USD | 29 | 8 | 5 | 5 | 0 / 2 | |
| 449 | 487M USD | 29 | 8 | 77 | 29 | 2 / 2 | |
| 449 | 423M USD | 29 | 8 | 81 | 24 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score